Monday - November 3, 2025
FDA Issues Warning Letter to Royal Philips
October 29, 2025
WASHINGTON, Oct. 29 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Royal Philips from the Center for Devices and Radiological Health:

* * *

Recipient: Roy Jakobs, Chief Executive Officer, Royal Philips, Amstelplein 2, 1096 BC Amsterdam, Netherlands, (b)(6)@philips.com

Issuing Office: Center for Devices and Radiological Health, United States

WARNING LETTER

CMS . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products